439
Participants
Start Date
February 3, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
September 30, 2028
BNT327
Solution for intravenous infusion
Atezolizumab
Concentrate for solution for intravenous infusion
Etoposide
Solution for infusion
Carboplatin
Solution for infusion
Acibadem Adana Hospital, Adana
Seyhan Medical Park Hospital, Adana
Baskent University Adana Turgut Noyan Application and Research Center, Adana
Calvary Mater Newcastle, Waratah
Cancer Care Wollongong Pty Limited, Wollongong
Western Health Sunshine Hospital, St Albans
Olivia Newton-John Cancer Wellness & Research centre, Heidelberg
Peninsula & South Eastern Haematology and Oncology Group, Frankston
Severance Hospital, Yonsei University Health System, Seoul
The Queen Elizabeth Hospital, Woodville
Icon Cancer Centre Kurralta Park, Kurralta Park
Asan Medical Center (AMC), Seoul
Gulhane Training and Research Hospital, Ankara
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara
Hacettepe University Medical Faculty Hospital, Ankara
Samsung Medical Center, Seoul
Memorial Ankara Hospital, Ankara
Gazi University, Medical Faculty Hospital, Ankara
Liv Hospital Ankara, Ankara
Ankara Bilkent City Hospital, Ankara
Korea University Guro Hospital, Seoul
National Cancer Center, Goyang-si
The Catholic University Of Korea, St. Vincent's Hospital, Suwon
Ajou University Hospital, Suwon
Gachon University Gil Medical Center, Incheon
Hematology Oncology Associates of Fredericksburg, Inc., Fredericksburg
Koc Universitesi Hastanesi (Koc University Hospital), Istanbul
Medical Park Florya Hospital, Istanbul
Clermont Oncology Center, Clermont
Yeditepe University Kosuyolu Hospital, Istanbul
Medical Point Izmir Hospital, Izmir
University of Tennessee Medical Center, Knoxville
Baptist Cancer Center, Southaven
Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul
Kocaeli University Medical Faculty Hospital, Kocaeli
Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
McFarland Clinic, Ames
Helen G. Nassif Community Cancer Center, Cedar Rapids
Gyeongsang National University Hospital (GNUH), Jinju
Sakarya University Training and Research Hospital, Sakarya
Nebraska Hematology-Oncology (NHO), Lincoln
Millennium Research and Clinical Development, LLC, Houston
Jilin Cancer Hospital, Changchun
Akdeniz University Hospital, Antalya
The Christie NHS Foundation Trust, Manchester
Royal Marsden Hospital (RMH) - Royal Marsden NHS Foundation Trust, Chelsea
Royal Marsden Hospital (Sutton) - Royal Marsden NHS Foundation Trust, Sutton
Huddersfield Royal Infirmary - Calderdale and Huddersfield NHS Foundation Trust, Huddersfield
Northern Centre for Cancer Care - The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Nottingham University Hospitals NHS Trust - Nottingham City Hospital, Nottingham
Churchill Hospital - Oxford University Hospitals NHS Foundation Trust, Oxford
Ninewells Hospital and Medical School - Tayside Health Board, Dundee
Torbay and South Devon NHS Foundation Trust, Torquay
Royal Stoke University Hospital - University Hospitals of North Midlands NHS Trust, Stoke-on-Trent
Velindre NHS Trust, Velindre Cancer Centre, Cardiff
New Cross Hospital, Wolverhampton
St James's University Hospital - Leeds Teaching Hospitals NHS Trust, Leeds
Lead Sponsor
Collaborators (1)
Biotheus Inc.
INDUSTRY
BioNTech SE
INDUSTRY